Yanfeng Zhu Selected Research

delphinidin

1/2022	Combined Network Pharmacology and Cytology Experiments to Identify Potential Anti-Breast Cancer Targets and Mechanisms of Delphinidin.
12/2021	Delphinidin induces cell cycle arrest and apoptosis in HER-2 positive breast cancer cell lines by regulating the NF-κB and MAPK signaling pathways.
10/2019	Delphinidin suppresses breast carcinogenesis through the HOTAIR/microRNA-34a axis.
1/2018	Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells.
3/2017	[Delphinidin induces autophagy in HER-2+ breast cancer cells via inhibition of AKT/mTOR pathway].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanfeng Zhu Research Topics

Disease

5	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2017
5	Neoplasms (Cancer) 01/2022 - 09/2017
1	COVID-19 11/2022
1	Non-Muscle Invasive Bladder Neoplasms 06/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 02/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2019
1	Carcinogenesis 10/2019
1	Prostatic Neoplasms (Prostate Cancer) 05/2019
1	Osteoporosis 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Infections 12/2016
1	Rheumatoid Arthritis 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016

Drug/Important Bio-Agent (IBA)

5	delphinidinIBA 01/2022 - 03/2017
4	Anthocyanins (Anthocyanin)IBA 01/2022 - 01/2018
3	Biological ProductsIBA 01/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2016
1	VaccinesIBA 11/2022
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2022
1	Gemcitabine FDA Link 06/2022
1	Pharmaceutical PreparationsIBA 06/2022
1	pirarubicinIBA 06/2022
1	AntioxidantsIBA 01/2022
1	Progesterone FDA LinkGeneric 01/2022
1	FlavonoidsIBA 12/2021
1	Cyclin B1IBA 12/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	SurvivinIBA 01/2021
1	Diphtheria ToxinIBA 01/2021
1	osthol (osthole)IBA 02/2020
1	Glutamic Acid (Glutamate)FDA Link 02/2020
1	Arsenic Trioxide (Trisenox)FDA Link 12/2019
1	MicroRNAs (MicroRNA)IBA 10/2019
1	Glycogen Synthase (Synthase I)IBA 10/2019
1	CateninsIBA 10/2019
1	Long Noncoding RNAIBA 05/2019
1	CRM197 (non-toxic variant of diphtheria toxin)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 09/2017
1	Epidermal Growth Factor (EGF)IBA 03/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 03/2017
1	Eukaryotic Initiation Factor-4EIBA 03/2017
1	B-Cell Activating FactorIBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2016
1	Drug Therapy (Chemotherapy) 06/2022
1	Debridement 12/2016